Published on
May 21, 2026
- 05:24 GMT
UChicago Medicine builds on years of experience with new oral IBD treatment
A growing body of real-world evidence continues to show that upadacitinib, the first oral medication approved by the FDA to treat Crohn’s disease and the second drug in its class for ulcerative colitis, is not only safe but fast acting and effective. This …
Distribution channels:
Healthcare & Pharmaceuticals Industry
